[
    {
        "year": "2019",
        "ingredients": "BYDUREON BCise exenatide EXENATIDE EXENATIDE POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 63000 MW) SUCROSE CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM SODIUM CHLORIDE POLYSORBATE 20 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE WATER",
        "n_ingredients": 7,
        "drug_name": "BYDUREON BCise",
        "route": "SUBCUTANEOUS"
    },
    {
        "year": "2019",
        "ingredients": "QTERN dapagliflozin and saxagliptin DAPAGLIFLOZIN DAPAGLIFLOZIN SAXAGLIPTIN HYDROCHLORIDE SAXAGLIPTIN ANHYDROUS ANHYDROUS LACTOSE CROSCARMELLOSE SODIUM FERROUS OXIDE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYVINYL ALCOHOL, UNSPECIFIED POLYETHYLENE GLYCOL 400 SILICON DIOXIDE TALC TITANIUM DIOXIDE biconvex 5;10;1122 QTERN dapagliflozin and saxagliptin DAPAGLIFLOZIN DAPAGLIFLOZIN SAXAGLIPTIN HYDROCHLORIDE SAXAGLIPTIN ANHYDROUS ANHYDROUS LACTOSE CROSCARMELLOSE SODIUM FERROUS OXIDE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYVINYL ALCOHOL, UNSPECIFIED POLYETHYLENE GLYCOL 400 SILICON DIOXIDE TALC TITANIUM DIOXIDE light reddish biconvex 5;5;1120",
        "n_ingredients": 3,
        "drug_name":"QTERN",
        "route": "ORAL"
    }
]